2,247
Views
3
CrossRef citations to date
0
Altmetric
Gastroenterology

Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies

ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 691-699 | Received 17 Jan 2023, Accepted 24 Mar 2023, Published online: 11 Apr 2023

References

  • Gurbulak B, Üçüncü MZ, Yardımcı E, et al. Impact of anxiety on sedative medication dosage in patients undergoing esophagogastroduodenoscopy. Wideochir Inne Tech Maloinwazyjne. 2018;13:192–198.
  • Felley C, Perneger TV, Goulet I, et al. Combined written and oral information prior to gastrointestinal endoscopy compared with oral information alone: a randomized trial. BMC Gastroenterol. 2008;8:22.
  • Vaessen HHB, Knape JTA. Considerable variability of procedural sedation and analgesia practices for gastrointestinal endoscopic procedures in Europe. Clin Endosc. 2016;49:47–55.
  • Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg. 1970;49(6):924–934.
  • Saunders R, Davis JA, Kranke P, et al. Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries. Ther Clin Risk Manag. 2018;14:393–401.
  • Triantafillidis JK, Merikas E, Nikolakis D, et al. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol. 2013;19:463–481.
  • Keam SJ. Remimazolam: first approval. Drugs. 2020;80:625–633.
  • EMC. Propofol 20 mg/ml Emulsion for injection/infusion [Internet]. Available from: https://www.medicines.org.uk/emc/product/11294/smpc#gref
  • Shenbagaraj L, Thomas-Gibson S, Stebbing J, et al. Endoscopy in 2017: a national survey of practice in the UK. Frontline Gastroenterol. 2019;10:7–15.
  • Hinkelbein J, Lamperti M, Akeson J, et al. European society of anaesthesiology and european board of anaesthesiology guidelines for procedural sedation and analgesia in adults. Eur J Anaesthesiol. 2018;35:6–24.
  • Pambianco DJ, Brooks DC. New horizons for sedation: the ultrashort acting benzodiazepine remimazolam. Tech Gastrointest Endosc. 2016;18:22–28.
  • Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation During bronchoscopy. Chest. 2019;155:137–146.
  • Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88:427–437.e6.
  • Pambianco DJ, Borkett KM, Riff DS, et al. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2016;83:984–992.
  • Rex DK, Bhandari R, Lorch DG, et al. Safety and efficacy of remimazolam in high risk colonoscopy: a randomized trial. Dig Liver Dis. 2021;53:94–101.
  • Yichang Humanwell Pharmaceutical Co Ltd. RF-5 clinical trial report: a multicentre, randomised, single-blind, positive-controlled, parallel group, phase IIb clinical study of the efficacy and safety of remimazolam besylate for injection in patients undergoing colonoscopy for diagnostic or therapeutic reasons. Data on file; 2018.
  • Yichang Humanwell Pharmaceutical Co Ltd. RF-6 clinical trial report: a multicentre, randomised, single-blind, positive-controlled, parallel group, phase III clinical study of the efficacy and safety of remimazolam besylate for injection in patients undergoing colonoscopy for diagnostic or therapeutic reasons. Data on file; 2018.
  • European Medicines Agency. Summary of product characteristics: remimazolam (Byfavo) [Internet]. EMA; 2021. Available from: https://www.ema.europa.eu/en/documents/product-information/byfavo-epar-product-information_en.pdf
  • The Danish Medicine Council. Valuation of unit costs. Copenhagen (Denmark): The Danish Medicines Council; 2020.
  • Sørensen. Omkostninger ved administration af biologiske lægemidler; 2011.
  • Jakobsen M, Rasmussen SR, Kjelberg J. Differences in costs of administration of biologics – a case study within gastroenterology [Forskelle i omkostninger ved administrering af biologiske lægemidler – Et casestudie inden for gastroenterologien]. Aarhus and Copenhagen: Vive; 2015.
  • The Danish Medicines Council. Værdisætning af enhedsomkostninger; 2020.
  • Jakobsen M, Rasmussen SR, Kjellberg J. Forskelle i omkostninger ved administrering af biologiske lægemidler: et casestudie inden for gastroenterologien [Internet]. KORA; 2015. Available from: https://pure.vive.dk/ws/files/2041662/10724_administrering_biologiske_laegemidler.pdf
  • Eurostat. Surgical operations and procedures statistics [Internet]. [cited 2021 May 19]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Surgical_operations_and_procedures_statistics#Increasing_and_decreasing_surgical_operations_and_procedures
  • Region Nordjylland. Sedation and analgesia for endoscopies: about the drugs [sedation og analgesi ved endoskopi; vedr. medikamenterne] [Internet]. Available from: https://pri.rn.dk/Sider/19475.aspx#a_Toc277144764
  • Trevisani L, Zelante A, Sartori S. Colonoscopy, pain and fears: is it an indissoluble trinomial. World J Gastrointest Endosc. 2014;6:227–233.
  • Blayney MR. Procedural sedation for adult patients: an overview. Contin Educ Anaesth Crit Care Pain. 2012;12:176–180.
  • South West Anaesthetic Research Matrix. Sedation practice in six acute hospitals – a snapshot survey. Anaesthesia. 2015;70:407–415.